期刊文献+

线粒体损伤与糖尿病心肌病发病关系的研究进展 被引量:18

Research progress of mitochondria in diabetic cardiomyopathy
下载PDF
导出
摘要 糖尿病心肌病(diabetic cardiomyopathy,DCM)是糖尿病患者的主要心血管并发症之一,目前,对DCM缺乏有效的治疗措施,而且其病理生理学相当复杂。线粒体是心肌细胞能量的主要来源,在调节能量代谢中起着重要作用。糖尿病患者线粒体肿胀、片段化,从而引起线粒体功能受损,提示线粒体形态受损和功能异常可能在DCM发病中起重要作用。该文从线粒体能量代谢异常、线粒体氧化应激增强、线粒体动力学改变、线粒体心磷脂变化、线粒体钙紊乱等方面,综述了线粒体损伤与DCM发病之间的关系。 Diabetic cardiomyopathy(DCM)is one of the major cardiovascular complications of diabetes mellitus.Currently,there is a lack of effective treatment for DCM,and its pathophysiology is quite complex.Mitochondria are the main source of cardiomyocyte energy and play an important role in regulating energy metabolism.Mitochondria are swollen and fragmented in diabetic patients,leading to impaired mitochondrial function,suggesting that mitochondrial damage and dysfunction may play an important role in the pathogenesis of DCM.In this paper,the relationship between mitochondrial damage and the pathogenesis of DCM was reviewed from the aspects of abnormal mitochondrial energy metabolism,mitochondrial oxidative stress enhancement,mitochondrial kinetics,mitochondrial heart lecithin change,and mitochondrial calcium disorder.
作者 刘涛 李晶 鲍翠玉 LIU Tao;LI Jing;BAO Cui-yu(School of Pharmacy,Hubei Province Key Lab on Cardiovascular,Cerebrovascular,and Metabolic Disorders,Hubei University of Science and Technology,Xianning Hubei 437100,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2018年第4期456-458,共3页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No51703055);湖北省自然科学基金资助项目(No2017CFB699,2015CFC773);湖北省教育厅科学研究计划项目(NoB201696);湖北科技学院糖尿病专项基金(No2016-18XZ09,14ZX-02)
关键词 糖尿病心肌病 线粒体损伤 能量代谢异常 氧化应激 心磷脂 钙紊乱 diabetic cardiomyopathy mitochondrial injury abnormal energy metabolism oxidative stress cardiolipin calcium disorder
  • 相关文献

参考文献4

二级参考文献28

  • 1李晓博,牟忠卿,陈丽,付艺凌,张岩,咸玉欣,侯新国.糖尿病大鼠肾脏组织氧化应激及其在糖尿病肾病发病中的意义[J].中国病理生理杂志,2006,22(4):806-809. 被引量:24
  • 2万静,刘丽梅.氧化应激—抗氧化系统与糖尿病肾病[J].国际内分泌代谢杂志,2006,26(B04):18-20. 被引量:12
  • 3Rowe G C ,Jiang A,Arany Z. PGC-1 coactivators in cardiac devel- opment and disease [ J]. Circ Res,2010,1U7(7 ) :825 - 38.
  • 4Aranv Z,He H,Lin J,et al. Transcriptional coactivator PGC-1 al- pha controls the energy state and contracrile function of cardiac muscle [ J ]. Cell Metab ,2005 ,1 (4) :259 - 71.
  • 5Sebastiani M, Giordano C, Nediani C, et al. Induction of mitochon- drial biogenesis is a maladaptive mechanism in mitochondrial car- diomyopatbies [ J]. J Am CoU Cardiol,2007,50(14) : 1362 - 9.
  • 6Scarpulla R C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network [ J]. Biochim Biophys Acta,2011,1813 (7) : 1269 - 78.
  • 7Diaz F, Moraes C T. Mitochondrial biogenesis and turnover [ J ], Cell Calcium ,2008, 44( 1 ) :24 - 35.
  • 8Pagel-Langenickel I, Bao J, Joseph J J, et al. PGC-lalpha integrates insulin signaling, mitochondrial regulation and bioenergetic func- tion in skeletal muscle [ J ]. J Biol Chem, 2008,283 (33) :22464 -72.
  • 9Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 [ J ]. Cell, 1999,9$ ( 1 ) : 115 - 24.
  • 10Lin J, Handschin C, Spiegelman B M. Metabolic control through the PGC-I family of transcription coactivators [ J ]. Cell Met, 2005,1(6) :361 -70.

共引文献59

同被引文献161

引证文献18

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部